A comprehensive longitudinal study spanning more than four decades has provided significant evidence that moderate daily caffeine consumption—specifically two to…
Read More
Tirzepatide Shows Promising Adjunct Benefits in Type 1 Diabetes Management, Meta-Analysis Presented at European Congress on Obesity Suggests
The burgeoning field of GLP-1 receptor agonists, celebrated for their transformative impact on obesity and type 2 diabetes (T2D) management,…
Read More
Salk Institute Identifies Med14 Protein as Key Regulator for GLP-1 Agonists’ Long-Term Pancreatic Health Benefits
Salk Institute researchers have pinpointed a crucial protein, Med14, that acts as a molecular bridge connecting GLP-1 agonist drugs to…
Read MoreYOU MAY HAVE MISSED
